CDC's Advisory Committee on Immunization Practices approved in October 2014 the Recommended Adult Immunization Schedule for 2015. The schedule provides a summary of ACIP recommendations for vaccines routinely recommended for adults. Changes from the previous year's schedule include the recommendation for routine administration of the 13-valent pneumococcal conjugate vaccine (PCV13) in series with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for all adults aged 65 years or older, a revision on contraindications and precautions for the live attenuated influenza vaccine, and FDA's decision to expand the approved age for use of recombinant influenza vaccine (RIV). The RIV is now approved for all adults aged 18 and older, instead of adults aged 18 through 49. The 2015 adult immunization schedule was reviewed and approved by the American College of Physicians, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, and American College of Nurse-Midwives.